SubHero Banner
Text

October 2021

Core topics in this month’s edition include:

  • Cyltezo (adalimumab-adbm) - first interchangeable biosimilar to Humira
  • Rethymic (allogeneic processed thymus tissue-agdc) - new orphan drug approval
  • Janssen, Moderna and Pfizer COVID-19 vaccines updates

Download PDF

Text